Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
130 studies found for:    "Choroiditis"
Show Display Options
Rank Status Study
1 Recruiting Safety, Tolerability and Efficacy of Intravitreal LFG316 in Patients With Multifocal Choroiditis and Panuveitis (MCP)
Conditions: Multifocal Choroiditis;   Panuveitis;   Active Vitritis
Interventions: Drug: LFG316;   Drug: Conventional Therapy
2 Completed Intravitreal Bevacizumab for Inflammatory Neovascular Membranes
Conditions: Vogt Koyanagi Harada Disease;   Serpiginous Choroiditis;   Multifocal Choroiditis
Interventions: Drug: Bevacizumab;   Procedure: Intravitreal Injection of Bevacizumab
3 Completed Evaluation and Treatment of Patients With Inflammatory Eye Diseases
Conditions: Choroiditis;   Iridocyclitis;   Iritis;   Retinal Disease
Intervention:
4 Completed Intravitreal Bevacizumab in Recalcitrant Inflammatory Ocular Neovascularization
Conditions: Neovascularization;   Tuberculosis;   Multifocal Serpiginous Choroiditis;   Harada Toxoplasmosis
Intervention:
5 Withdrawn Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMD
Conditions: Choroidal Neovascularization;   Myopia;   Punctate Inner Choroidopathy (PIC);   Multifocal Choroiditis;   Ocular Histoplasmosis Syndrome;   Central Serous Chorioretinopathy (CSC);   Angioid Streaks;   Trauma, or Hereditary Eye Diseases
Interventions: Drug: Bevacizumab (Avastin; Genentech, Inc.);   Drug: Bevacizumab, Dexamethasone, Verteporfin Photodynamic Therapy
6 Completed Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy
Conditions: Coats' Disease;   Idiopathic Retinal Telangiectasia;   Retinal Angiomatous Proliferation;   Polypoidal Choroidal Vasculopathy;   Pseudoxanthoma Elasticum;   Pathological Myopia;   Multi-focal Choroiditis;   Rubeosis Iridis;   Von Hippel Lindau Disease;   BEST VITELLIFORM MACULAR DYSTROPHY, MULTIFOCAL (Disorder)
Intervention: Drug: ranibizumab injection (0.5 mg)
7 Completed Safety and Efficacy of AIN457 in Noninfectious Uveitis
Condition: Active Uveitis That is Not From an Infection.
Interventions: Drug: AIN457 subcutaneous dose;   Drug: AIN457 low dose (i.v);   Drug: AIN457 high dose (i.v)
8 Recruiting Efficacy of Gevokizumab in the Treatment of Patients With Behçet's Disease Uveitis (EYEGUARD™-B)
Condition: Behcet's Uveitis
Interventions: Drug: Gevokizumab;   Drug: Placebo
9 Completed Vitamin E to Treat Uveitis-Associated Macular Edema
Conditions: Cystoid Macular Edema;   Uveitis
Intervention: Drug: Vitamin E
10 Recruiting Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Condition: Uveitis
Interventions: Drug: Placebo;   Drug: Dose 1 gevokizumab;   Drug: Dose 2 gevokizumab
11 Completed
Has Results
A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Intermediate or Posterior Uveitis
Conditions: Intermediate Uveitis;   Posterior Uveitis
Interventions: Drug: Dexamethasone;   Drug: dexamethasone;   Drug: Sham injection
12 Completed The Safety and Efficacy of Chicken Type II Collagen on Uveitis Associated With Juvenile Rheumatoid Arthritis
Conditions: Arthritis, Juvenile Rheumatoid;   Uveitis
Intervention: Drug: Chicken type II collagen
13 Unknown  Quality of Life and Visual Function in Uveitis Patients
Conditions: Anterior Uveitis;   Posterior Uveitis;   Panuveitis;   Uveitis
Intervention:
14 Unknown  Everolimus for the Treatment of Uveitis Unresponsive to Cyclosporine A
Condition: Uveitis
Intervention: Drug: everolimus
15 Completed Observation on the Treg in the Uveitis Patients
Condition: Uveitis
Intervention:
16 Completed Acrylate Intraocular Lenses in Cataract Surgery of Uveitis Patients
Conditions: Uveitis;   Cataract
Intervention: Device: intraocular lenses: Two foldable, acrylic, sharp edged IOLs: AcrySof™ (AcrySof SA60AT, Alcon), and Akreos adapt™ (Bausch & Lomb)
17 Recruiting Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious Uveitis
Conditions: Uveitis;   Macular Edema;   Uveitis, Posterior;   Uveitis, Anterior;   Panuveitis;   Uveitis, Intermediate
Interventions: Drug: 4 mg CLS-TA;   Drug: 0.8 mg CLS-TA
18 Unknown  To Compare Intravitreal Clindamycin & Dexamethasone With Classic Treatment of Toxoplasmic Retinochoroiditis
Condition: Chorioretinitis
Interventions: Drug: pyrimethamine-sulfadiazine + prednisolone;   Drug: Clindamycin+Dexamethasone
19 Completed Combination Daclizumab/Denileukin Diftitox to Treat Uveitis
Condition: Non-Infectious Intermediate and Posterior Uveitis
Intervention: Drug: Daclizumab
20 Unknown  Intravitreal Adalimumab in Refractory Diabetic Retinopathy, Choroidal Neovascularization or Uveitis: A Pilot Study
Conditions: Uveitis;   Diabetic Retinopathy;   Choroidal Neovascularization
Intervention: Drug: adalimumab

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years